Triflunordazepam

A benzodiazepine derivative

Triflunordazepam
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Triflunordazepam is a benzodiazepine derivative that is used for its anxiolytic, sedative, and muscle relaxant properties. It is a psychoactive drug that acts on the central nervous system by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor.

Pharmacology

Triflunordazepam, like other benzodiazepines, works by binding to the benzodiazepine site on the GABA_A receptor. This binding increases the frequency of chloride ion channel opening events, leading to an increased inhibitory effect of GABA in the central nervous system. This results in the drug's calming effects, making it useful in the treatment of anxiety disorders, insomnia, and muscle spasms.

Clinical Use

Triflunordazepam is primarily prescribed for the management of severe anxiety and insomnia. It may also be used as a premedication for anesthesia or for the treatment of seizures in certain cases. Due to its potential for dependence and tolerance, it is generally recommended for short-term use.

Side Effects

Common side effects of triflunordazepam include drowsiness, dizziness, and fatigue. More serious side effects can include respiratory depression, hypotension, and paradoxical reactions such as increased anxiety or aggression. Long-term use can lead to physical dependence and withdrawal symptoms upon discontinuation.

Legal Status

The legal status of triflunordazepam varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and dependence. It is important for prescribers to adhere to local regulations when prescribing this medication.

Related pages

• Benzodiazepine
• GABA_A receptor
• Anxiolytic
• Sedative
• Muscle relaxant

• 
  Triflunordazepam